The Next Generation Biotech Media
February 24th, 2021 – The US Food and Drug Administration (USFDA) staff has deemed Johnson & Johnson’s single-shot COVID-19 vaccine safe and effective. In a briefing document published on Wednesday morning, …
Read More
Just when nations worldwide would have anticipated ending the year on a high with the recently approved COVID-19 vaccines, a new fast-spreading coronavirus variant, named B.1.1.7 (VUI-202012/01) has debuted on …
Read More
December 2, 2020 – In a major breakthrough in the COVID-19 vaccine race, the Medicines & Healthcare Products Regulatory Agency (MHRA) of the United Kingdom has given an emergency authorization …
Read More
November 23, 2020 – As we approach the end of the year, companies working on COVID-19 vaccines have started rolling out data from their Phase 3 trials – first Pfizer …
Read More
As COVID-19 continues to snowball into a massive health and economic concern, the world is anxiously anticipating a vaccine. While Russia’s vaccine was approved in August, several biopharma giants worldwide …
Read More
On August 4th, nearly two months since the inception of vaccine testing, Novavax announced preliminary data from its Phase 1 trial. The vaccine produced a promising immune response in the …
Read More
By Judy Ya-Hsuan Lin The clinical-stage biotech which hasn’t launched any product in the market previously is gearing towards an ambitious deadline to counter the COVID-19 pandemic. Maryland-based Novavax is …
Read More
By Sahana Shankar, Ph.D. Candidate As opposed to antibodies that bind to the receptor-binding domain, scientists discover a new antibody that binds to the N-Terminal Domain of the SARS-CoV-2’s spike …
Read More
By Ruchi Jhonsa, Ph.D. The BIO Digital Conference held between June 8-12, saw over 7000 participants from 64 countries come together for a two-day virtual meeting to discuss the progress …
Read More
By Sahana Shankar, Ph.D. Candidate European researchers report that SARS-CoV-2’s entry into the host cells is facilitated by Neuropilin-1 (NRP1), a cell receptor that, when inhibited with a monoclonal antibody, …
Read More